# Panbela Therapeutics, Inc. — Form D

Panbela Therapeutics, Inc. of Waconia, MN, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-29. $8.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-06-29
- Form: D
- Accession: 0001437749-22-016182
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $8.8M
- Investors: 70
- Date of first sale: 2022-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450719

## Issuer

- Name: Panbela Therapeutics, Inc.
- CIK: 0001029125
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 712 Vista Blvd #305, Waconia, MN, 55387
- Phone: 952-479-1196

## Officers, directors & promoters (22)

| Name | Role | Location |
| --- | --- | --- |
| Daniel T Donovan | Director | Waconia, MN |
| Robert D Schemel | Director | Waconia, MN |
| J. Robert Paulson | Director | St. Paul, MN |
| J. Robert Paulson, Jr. | Director | PLYMOUTH, MN |
| Daniel S Donovan | Director | Waconia, MN |
| Susan K Horvath | Executive Officer | Waconia, MN |
| Arthur J Fratamico | Director | Waconia, MN |
| Robert S Schemel | Director | Waconia, MN |
| Susan M Horvath | Executive Officer | Waconia, MN |
| Jennifer K Simpson | Director | New York, NY |
| Jennifer K Simpson | Executive Officer | New York, NY |
| D. ROBERT SCHEMEL | Director | WACONIA, MN |
| SCOTT ROBERT KELLEN | Executive Officer | WACONIA, MN |
| Jeffrey S Mathiesen | Director | Eden Prairie, MN |
| Suzanne T Gagnon | Director | Waconia, MN |
| Paul W Schaffer | Director | Waconia, MN |
| David B Kaysen | Director | Waconia, MN |
| David B Kaysen | Executive Officer | Waconia, MN |
| Michael T Cullen | Director | Waconia, MN |
| Michael T Cullen | Executive Officer | Waconia, MN |
| Dalvir S Gill | Director | Waconia, MN |
| Jeffrey E Jacob | Director | Tucson, AZ |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-01-05](https://search.stillhousedata.com/formd/0001437749-24-000715) | D | — | $2.0M |
| [2023-11-17](https://search.stillhousedata.com/formd/0001437749-23-032493) | D | — | $3.3M |
| [2019-09-09](https://search.stillhousedata.com/formd/0001567619-19-018041) | D | — | $2.5M |
| [2019-01-04](https://search.stillhousedata.com/formd/0001567619-19-000475) | D | $2.0M | $1.4M |
| [2018-03-06](https://search.stillhousedata.com/formd/0001140361-18-012181) | D | $20.0M | $840K |
| [2017-03-06](https://search.stillhousedata.com/formd/0001029125-17-000001) | D | $5.0M | $1.5M |
| [2016-06-27](https://search.stillhousedata.com/formd/0001611450-16-000002) | D | $5.0M | $2.0M |

## More

- [CIK 1029125 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1029125&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001437749-22-016182.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.